Loading…
Omnicell, Inc. is projected to rise to $54.98 by 2027, a +28% move from its current price of $43.12. OMCL is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $42.29 | $43.14 | $44.02 | +0.05% |
| May 30 | $41.96 | $43.17 | $44.41 | +0.11% |
| May 31 | $41.71 | $43.19 | $44.72 | +0.16% |
| Jun 1 | $41.51 | $43.21 | $44.99 | +0.22% |
| Jun 2 | $41.34 | $43.24 | $45.22 | +0.27% |
| Jun 3 | $41.19 | $43.26 | $45.44 | +0.33% |
| Jun 4 | $41.05 | $43.29 | $45.65 | +0.38% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $41.05 | $43.29 | $45.65 | +0.38% |
| Week 2 | $40.31 | $43.45 | $46.84 | +0.77% |
| Week 3 | $39.78 | $43.62 | $47.82 | +1.15% |
| Week 4 | $39.37 | $43.78 | $48.69 | +1.54% |
| Week 5 | $39.03 | $43.95 | $49.50 | +1.93% |
| Week 6 | $38.74 | $44.12 | $50.25 | +2.32% |
| Week 7 | $38.48 | $44.29 | $50.97 | +2.71% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services.
In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc.
in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
Omnicell, Inc. (OMCL) is a healthcare technology company categorized in Healthcare. Its current price is $44.41 with a market cap of $2.02B and a ranking of 1995. The price outlook shown in the forecast indicates mixed-to-upside potential over the coming years, with neutral sentiment in 2026 and bullish momentum expected from 2027 through 2050, culminating in substantial upside by 2050.
The forecast provides year-by-year avg prices and ROIs, highlighting meaningful long-term upside while emphasizing that these are estimates rather than guarantees.
A major floor 25.0% below — a decisive break under it would weaken the trend.
The nearest floor, 15.7% below — buyers have tended to step in here.
The nearest ceiling, 5.5% above — a clean break opens room to run.
A major ceiling 19.0% above — clearing it would confirm fresh momentum.
Key OMCL support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of OMCL market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $44.02 | Sell | $43.75 | Sell |
| MA 10 | $43.72 | Sell | $43.65 | Sell |
| MA 20 | $43.47 | Sell | $42.79 | Buy |
| MA 50 | $38.75 | Buy | $40.92 | Buy |
| MA 100 | $41.18 | Buy | $40.02 | Buy |
| MA 200 | $38.04 | Buy | $38.72 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 54.77 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -49.98 | Neutral |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.23 | Sell |
| ROC (12) | -1.60 | Sell |
| Bollinger %B (20,2) | 0.37 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 0.60 | Buy |
| Awesome (5,34) | 3.08 | Buy |
| Ultimate (7,14,28) | 50.38 | Neutral |
| Momentum (10) | -0.58 | Sell |
| Aroon Osc (25) | 12.00 | Buy |
| Hull MA (9) | 44.04 | Sell |
| ADX (14) | 22.04 | Buy |
| ATR (14) | 0.79 | Info |
The 30-day technical picture is bullish. RSI14 is 60, signaling constructive momentum, with the near-term tilt supported by positive sentiment. The 50-day simple moving average stands at $38.38 and the 200-day simple moving average at $37.92, suggesting a near-term uptrend compared with longer-term trend lines.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $32.35 | $43.12 | $61.02 | 0% | Neutral | |
| $44.73 | $54.98 | $70.89 | +28% | Bullish | |
| $49.14 | $61.60 | $81.61 | +43% | Bullish | |
| $49.35 | $62.86 | $85.12 | +46% | Bullish | |
| $48.71 | $62.92 | $86.80 | +46% | Bullish | |
| $56.13 | $73.46 | $102.99 | +70% | Bullish | |
| $62.32 | $82.54 | $117.45 | +91% | Bullish | |
| $68.00 | $91.08 | $131.34 | +111% | Bullish | |
| $74.73 | $101.16 | $147.70 | +135% | Bullish | |
| $74.20 | $101.46 | $149.85 | +135% | Bullish | |
| $107.84 | $154.29 | $239.31 | +258% | Bullish | |
| $176.89 | $272.99 | $455.21 | +533% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $32.35 | $43.12 | $50.45 | +0.00% |
| June 2026 | $37.30 | $43.55 | $51.88 | +1.00% |
| July 2026 | $38.58 | $45.32 | $54.53 | +4.06% |
| August 2026 | $39.13 | $46.20 | $56.01 | +1.93% |
| September 2026 | $38.69 | $45.85 | $55.94 | -0.74% |
| October 2026 | $39.36 | $46.82 | $57.45 | +2.10% |
| November 2026 | $40.79 | $48.68 | $60.03 | +3.97% |
| December 2026 | $41.15 | $49.25 | $61.02 | +1.19% |
Click any year to see its month-by-month OMCL forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The OMCL price prediction for 2026 points to an average of $43.12 (low $32.35, high $61.02) — a potential gain of 0% on today's $43.12. Price action looks broadly range-bound.
In 2027, OMCL is projected to trade between $44.73 and $70.89, averaging $54.98 — a potential gain of +28% from today's $43.12. That is up +28% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Omnicell, Inc.'s 2028 outlook centres on $61.60, within a $49.14 to $81.61 range. That is up +12% on the projected 2027 average. That marks a +43% change versus current levels. Momentum favours further upside here.
By 2029, OMCL could reach as high as $85.12, with a base case around $62.86 and support toward $49.35 — roughly +46% from $43.12. Buyers look set to stay in control over this stretch.
Expect OMCL to range from $48.71 to $86.80 through 2030. The $62.92 average target implies a +46% move from current prices. That is up 0% on the projected 2029 average. Momentum favours further upside here.
The OMCL price prediction for 2031 points to an average of $73.46 (low $56.13, high $102.99) — a potential gain of +70% on today's $43.12. Buyers look set to stay in control over this stretch.
In 2032, OMCL is projected to trade between $62.32 and $117.45, averaging $82.54 — a potential gain of +91% from today's $43.12. That is up +12% on the projected 2031 average. Momentum favours further upside here.
Omnicell, Inc.'s 2033 outlook centres on $91.08, within a $68.00 to $131.34 range. That is up +10% on the projected 2032 average. That marks a +111% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, OMCL could reach as high as $147.70, with a base case around $101.16 and support toward $74.73 — roughly +135% from $43.12. Momentum favours further upside here.
Expect OMCL to range from $74.20 to $149.85 through 2035. The $101.46 average target implies a +135% move from current prices. That is up 0% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The OMCL price prediction for 2040 points to an average of $154.29 (low $107.84, high $239.31) — a potential gain of +258% on today's $43.12. Momentum favours further upside here.
In 2050, OMCL is projected to trade between $176.89 and $455.21, averaging $272.99 — a potential gain of +533% from today's $43.12. That is up +77% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in OMCL today (≈ 23.191095 OMCL) could be worth
$6,330.93
+$5,330.93 (+533%) by 2050 · US Dollar
Based on the average projected OMCL price of $272.99 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in OMCLwould be worth at today's price.
$1,000 invested in OMCL on May 27, 2025 (≈ 33.772374 OMCL) would be worth
$1,456.26
+$456.26 (+45.6%) today · 1.46× · US Dollar
Based on a OMCL entry price of $29.61 vs. today's $43.12.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $44.72 | $964.22 | -3.6% |
| 1 month ago | $37.63 | $1,145.89 | +14.6% |
| 3 months ago | $41.93 | $1,028.38 | +2.8% |
| 6 months ago | $36.51 | $1,181.05 | +18.1% |
| 1 year ago | $29.61 | $1,456.26 | +45.6% |
| All time (5.0y) ago | $138.34 | $311.7 | -68.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our OMCL forecast.
Our base-case forecast reaches $86.00 around 2033.
Implied market cap at $86.00: $3.91B
Over the multi-year horizon, the forecast shows bullish sentiment through 2027 and beyond, with rising average prices. The path envisions continued upside with notable milestones: 2030 avg $66.30 and 2040 avg $165.77, then 2050 avg $296.09. Corresponding ROIs are 49.3% in 2030, 273.3% in 2040, and 566.7% in 2050, underscoring substantial long-run upside.
The forecast also shows a progression from 2027 avg $57.27 (ROI 28.9%) and 2028 avg $64.12 (ROI 44.4%) through 2029 avg $65.44 (ROI 47.4%). While this points to strong potential, these are estimates and not guarantees, and the outlook notes the asset carries volatility—as reflected in the forecast and the 40% annualized volatility figure.
Tap a question to reveal the answer.
2030 avg $66.30; min $51.09; max $91.96; ROI 49.3%; sentiment BULLISH.
The forecast shows bullish sentiment from 2027 onward with rising averages (e.g., 2027 avg $57.27; 2028 avg $64.12; 2030 avg $66.30; 2040 avg $165.77; 2050 avg $296.09) and ROIs of 28.9%, 44.4%, 49.3%, 273.3%, and 566.7%, respectively, though 2026 is neutral. These are estimates, not guarantees.
Yes. 2034 forecast shows min $79.13, avg $107.77, max $158.46 with ROI 142.7 and bullish sentiment.
Current price: $44.41; Market cap: $2.02B.
Sentiment: BULLISH; RSI14: 60; SMA50: $38.38; SMA200: $37.92; Support: $35.01; Resistance: $45.51; 30-day range: $38.73 to $50.92; Annualized volatility: 40%.
Omnicell, Inc. Community Discussion
0Share your Omnicell, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.